- Home
- DNLI vs BHF Comparison
DNLI vs BHF Comparison
Compare DNLI & BHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | BHF |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | DNLI | BHF |
|---|---|---|
| Price | $19.76 | $60.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 8 |
| Target Price | $29.63 | ★ $58.14 |
| AVG Volume (30 Days) | ★ 1.5M | 730.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.09 |
| Revenue Next Year | $188.54 | $1.45 |
| P/E Ratio | ★ N/A | $4.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.57 | $43.16 |
| 52 Week High | $23.77 | $66.33 |
Technical Indicators
Market Signals| Indicator | DNLI | BHF |
|---|---|---|
| Relative Strength Index (RSI) | 47.31 | 47.50 |
| Support Level | $18.56 | $59.01 |
| Resistance Level | $20.12 | $60.77 |
| Average True Range (ATR) | 1.14 | 0.75 |
| MACD | -0.00 | 0.21 |
| Stochastic Oscillator | 25.65 | 88.57 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About BHF Brighthouse Financial Inc.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.